Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty
Active, not recruitingNot applicableNCT04028947
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Researchers are trying to determine if knee pain can be reduced by proactively protecting the free end of the saphenous nerve versus leaving it in the standard position during total knee arthroplasty.
Study details
- Official title
- Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty: A Double-Blind Randomized Controlled Trial
- Conditions
- Interventions
- Procedure: Prophylactic Infrapatellar Saphenous Neurectomy in Primary Total Knee Arthroplasty
- Sponsor
- Mayo Clinic
- Start date
- 2020-01-28
- Primary completion
- 2026-12
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Primary unilateral total knee arthroplasty candidate Exclusion Criteria: * Body Mass Index (BMI) \>40 * Inflammatory arthritis * Unable to follow up visits (long distance from Mayo Clinic) * Poor compliance risk * Health condition deemed by physician to preclude patient's ability to participate in the trial
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04028947